Cardiff Lexington Corporation (CDIF) |
|
Price: $0.0000
$0.00
%
|
Day's High:
| 0.00
| Week Perf:
|
|
Day's Low: |
$ 0.00 |
30 Day Perf: |
|
Volume (M): |
0 |
52 Wk High: |
$ 0.00 |
Volume (M$): |
$ 0 |
52 Wk Avg: |
$0.00 |
Open: |
$0.00 |
52 Wk Low: |
$0.00 |
|
|
Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
14 |
Employees |
- |
Revenues (TTM) (Millions $) |
7 |
Net Income (TTM) (Millions $) |
-2 |
Cash Flow (TTM) (Millions $) |
2 |
Capital Exp. (TTM) (Millions $) |
0 |
Cardiff Lexington Corporation
Cardiff Lexington Corporation is a publicly traded financial services company based in Florida, United States. The company primarily focuses on providing debt solutions and credit enhancement services to small and medium-sized businesses. They work with clients to restructure their current debt, improve credit scores, and increase access to financing options. Cardiff Lexington Corporation has a team of experienced professionals who analyze the financial situation of their clients and formulate customized strategies to help them achieve their financial goals.
Company Address: 3753 Howard Hughes Parkway Las Vegas 89169 NV
Company Phone Number: 628-2100 Stock Exchange / Ticker: CDIF
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Cardiff Lexington Corporation
Cardiff Lexington Corporation, a company in the Healthcare Facilities industry, has experienced a decline in financial performance during the January to March 31, 2024 time-frame. This is in stark contrast to the overall industry, which has seen a rise in revenue. The company's deficit per share for this time-frame increased to $-0.13, compared to $0.00 the previous year and $0.00 in the previous reporting period. This indicates a significant decline in profitability. Additionally, the revenue for Cardiff Lexington Corporation decreased by -6.95% to $2.66 million from $2.86 million in the comparable financial reporting period a year ago. However, there was an improvement in revenue on a sequential basis, with a 28.502% increase from $2.07 million. In terms of net deficit, the company realized a loss of $-0.283 million, which is larger than the $-0.016 million loss reported in the previous year. The operating earnings also saw a drastic decline, falling by -69.31% to $0.218992 million. As a result, the company's operating margin decreased to 8.23% from 24.94% in the first quarter of 2023.
|
Cardiff Lexington Corporation
Cardiff Lexington Corporation, despite facing a tough financial interval closing on December 31, 2023, has managed to achieve significant improvements and display resilience in the face of adversity. While CDIF's gain per share remained at $0.00, it is important to note that this is a significant leap from the previous year's loss of $-0.01 per share. Furthermore, CDIF's revenue experienced a considerable decline of -19.263% to $2.07 million from $2.57 million in the same reporting period a year ago. However, it is important to highlight that this dip was also seen across the entire Healthcare Facilities sector, making CDIF's performance in line with industry trends. Additionally, there was a sequential decrease of -39.748% from $3.44 million, indicating some challenges faced during the reporting period.
|
Cardiff Lexington Corporation
In the recently released financial report, Cardiff Lexington Corporation (CDIF) showcased a commendable performance, reaching a break-even point despite facing moderate revenue growth. The company's revenue rose by 2.302% to $3.44 million in the period ending September 30, 2023, compared to the same reporting season a year before. While CDIF's revenue increase trailed behind peers in the Healthcare Facilities sector, it demonstrated an 8.73% relative revenue rise compared to the same period last year. This article aims to analyze these financial results and speculate on their potential impact on the company's future. Steady Revenue Growth: With a revenue growth rate of 2.302%, Cardiff Lexington Corporation exhibited stability and consistency in its business operations. However, it is important to note that the growth rate falls below that of its peers in the Healthcare Facilities sector. Consequently, it becomes necessary for the company to strategize and identify areas for improvement in order to compete more effectively within the market.
|
Cardiff Lexington Corporation
Cardiff Lexington Corporation, a healthcare facilities company, has reported strong financial results for the second quarter of 2023. The company achieved a per share value of $0.00, which is the same as the previous year, but an improvement from the previous reporting season. In terms of revenue, Cardiff Lexington saw a significant increase of 11.245% to $3.48 million compared to $3.13 million in the same period last year. Sequentially, the company's revenue improved by 21.743% from $2.86 million. One notable achievement for Cardiff Lexington is its outperformance in the healthcare facilities sector. While the sector's peers reported a 7.53% increase in revenue in the same period, Cardiff Lexington surpassed them with its 11.245% growth. This indicates the company's success on the business side and its ability to generate higher revenue compared to its competitors.
|
Cardiff Lexington Corporation
Cardiff Lexington Corporation, a leader in the stock market, has recently released its financial earnings for the period ending March 31, 2023, and the results are nothing short of impressive. Despite a modest decline in revenue of -2.727% to $2.86 million year on year, the company managed to deliver unscathed earnings per share with an EPS of $0.00, showcasing its resilience and ability to weather challenges successfully. Comparing the figures to the preceding reporting period, Cardiff Lexington Corporation has made significant strides. In the previous period, earnings per share were reported at $-0.01, while revenue had increased by an impressive 11.498% to $2.57 million. This positive growth demonstrates the company's commitment to delivering value to its shareholders and sustaining its upward trajectory in the market.
|
Per Share |
Current |
Earnings (TTM) |
-0.31 $ |
Revenues (TTM) |
0.51 $
|
Cash Flow (TTM) |
0.13 $ |
Cash |
0.14 $
|
Book Value |
0.26 $
|
Dividend (TTM) |
0 $ |
|
Per Share |
|
Earnings (TTM) |
-0.31 $
|
Revenues (TTM) |
0.51 $ |
Cash Flow (TTM) |
0.13 $ |
Cash |
0.14 $
|
Book Value |
0.26 $ |
Dividend (TTM) |
0 $ |
|
|
|
Healthcare Segment |
|
100 % |
of total Revenue |
|
|